Michael Gelband’s RXO RXO Stock Holding History

Michael Gelband’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-286,945	Closed	-$4.51M	–	1948
2025 Q2	$4.51M	Buy	+286,945	New	+$4.35M	0.04%	457
2023 Q2	–	Sell	-257,942	Closed	-$5.07M	–	2193
2023 Q1	$5.07M	Buy	+257,942	New	+$4.95M	0.04%	508

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's RXO Position: Q3 2025 in Review

Michael Gelband sold out of RXO (RXO) in Q3 2025, closing a stake of 286,945 shares — an estimated $4.51M sold.

Michael Gelband first reported a position in RXO in Q1 2023 and held it in 2 quarters. The position peaked at $5.07M in Q1 2023. 266 funds tracked by Wall St. Rank hold RXO as of Q3 2025.

Michael Gelband reported no remaining RXO position as of Q3 2025 after selling out during the quarter.
Michael Gelband sold 286,945 RXO shares in Q3 2025, an estimated $4.51M.
Michael Gelband first reported a position in RXO in Q1 2023 and held it in 2 quarters.
Michael Gelband's RXO position peaked at $5.07M in Q1 2023.
266 funds tracked by Wall St. Rank held RXO as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.